Articles published by F-star Therapeutics, Inc.

F-star, an invoX Company, Announces Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generation Multi-Specific Antibodies

July 05, 2023

From F-star Therapeutics, Inc.

Via GlobeNewswire

F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma

March 07, 2023

From F-star Therapeutics, Inc.

Via GlobeNewswire

Tickers FSTX

invoX Pharma and F-star Therapeutics issue Joint Statement

January 26, 2023

From F-star Therapeutics, Inc.

Via GlobeNewswire

Tickers FSTX

F-star Therapeutics Presents Clinical Data on FS222, a CD137/PD-L1 Tetravalent Bispecific Antibody, at ESMO-IO 2022 Congress

December 06, 2022

From F-star Therapeutics, Inc.

Via GlobeNewswire

Tickers FSTX

F-star Therapeutics Announces Publication of Phase 1 Dose-Escalation Trial of FS118 in Patients with Advanced Cancer and PD-L1 Resistance in Clinical Cancer Research

November 07, 2022

From F-star Therapeutics, Inc.

Via GlobeNewswire

Tickers FSTX

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Oil & Gas Journal starts where other industry publications stop. It delivers more than information; it delivers context, adding details the others leave out and combining them with analysis, commentary, industry trends, and statistics.

Newsletters

The top stories, industry insights and relevant research, assembled by our editors and delivered to your inbox.

Connect

http://www.facebook.com/ogjonline

https://www.linkedin.com/company/oil-&-gas-journal

http://twitter.com/ogjonline

Affiliated Brands

About Us
Advertise
Do Not Sell or Share
Privacy Policy
Terms & Conditions